These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Studies with 8-azainosine, a cytotoxic nucleoside with antitumor activity. Bennett LL; Vail MH; Allan PW; Laster WR Cancer Res; 1973 Mar; 33(3):465-71. PubMed ID: 4689896 [No Abstract] [Full Text] [Related]
4. Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine. Danysz A; Wierzba K; Wutkiewicz M; Pniewska A; Pragłowski T; Burba-Anczewska I Arch Immunol Ther Exp (Warsz); 1984; 32(3):345-9. PubMed ID: 6395826 [TBL] [Abstract][Full Text] [Related]
5. Studies with analogues of purine nucleosides. LePage GA Natl Cancer Inst Monogr; 1971 Dec; 34():184-7. PubMed ID: 5140862 [No Abstract] [Full Text] [Related]
7. [Comparative study of toxicity, immunodepressive and tolerogenic activity of thiamiprine, azathioprine and cyclophosphane]. Filitis LN; Sorkina IuA; Pershin GN; Pevnitskiĭ LA; Solov'ev VV Farmakol Toksikol; 1971; 34(6):708-13. PubMed ID: 5139795 [No Abstract] [Full Text] [Related]
8. [Changes in the ultrastructure of adenocarcinoma-755 under the influence of 6-mercaptopurine]. Konovalova AL Vopr Onkol; 1971; 17(2):71-7. PubMed ID: 5567713 [No Abstract] [Full Text] [Related]
9. Mechanism of the growth inhibition potentiation arising from combination of 6-mercaptopurine with 6-(methylmercapto)purine ribonucleoside. Paterson AR; Wang MC Cancer Res; 1970 Sep; 30(9):2379-87. PubMed ID: 4319905 [No Abstract] [Full Text] [Related]
11. [Experimental model for simultaneous determination of mitostatic and lymphotoxic action of cytostatics and immunodepressants]. Petrov RV; Man'ko VM; Khaitov RM; Seslavina LS Tsitologiia; 1972 Jan; 14(1):121-7. PubMed ID: 5011336 [No Abstract] [Full Text] [Related]
12. Metabolic conditioning and metabolic actuation: experimental approaches to cancer chemotherapy involving combinations of metabolites and antimetabolites. Bloch A Cancer Chemother Rep; 1974; 58(4):471-7. PubMed ID: 4853172 [No Abstract] [Full Text] [Related]
13. [Studies on the influence of protein synthesis inhibitors on the formation of antibodies]. Thiel N; L'age-Stehr J; Wacker A Hoppe Seylers Z Physiol Chem; 1967 Nov; 348(11):1407-14. PubMed ID: 5586472 [No Abstract] [Full Text] [Related]
14. Inhibition of the primary immune response in man by anti-metabolites. Hersh EM; Carbone PP; Wong VG; Freireich EJ Cancer Res; 1965 Aug; 25(7):997-1001. PubMed ID: 5843275 [No Abstract] [Full Text] [Related]
15. [Immunosuppressive therapy with antimetabolites]. Gross D Ther Umsch; 1967 Apr; 24(4):147-53. PubMed ID: 5584943 [No Abstract] [Full Text] [Related]
17. The use of tumor growth kinetics in planning "curative" chemotherapy of advanced solid tumors. Schabel FM Cancer Res; 1969 Dec; 29(12):2384-9. PubMed ID: 5369685 [No Abstract] [Full Text] [Related]
18. Pharmacological immunosuppressive agents. Salaman JR Ulster Med J; 1981; 50(Suppl 1):36-42. PubMed ID: 7015656 [No Abstract] [Full Text] [Related]
19. Effect of sulfur containing purine nucleosides on immunological reaction in mice. I. Immunosuppressive effect of several alkylthio, aralkylthio and thiocyanatopurines and their ribonucleosides. Sekine T; Arai Y; Saneyoshi M Jpn J Exp Med; 1973 Oct; 43(5):369-75. PubMed ID: 4544070 [No Abstract] [Full Text] [Related]
20. [Nucleoside as an antineoplastic agent]. Ikehara M; Ubasawa S Saishin Igaku; 1970 May; 25(5):1028-38. PubMed ID: 4912176 [No Abstract] [Full Text] [Related] [Next] [New Search]